iBio, Inc. — Investor Relations & Filings
Filings indexed
690
across all filing types
Latest filing
2026-04-29
Regulatory Filings
Country
US
United States of America
Listing
US
IBIO
iBio, Inc. is a preclinical-stage biotechnology company that utilizes a proprietary, AI-driven drug discovery platform to develop novel antibody therapeutics. The company focuses on creating next-generation medicines for obesity and cardiometabolic disorders, aiming to enhance metabolic health. Its technology stack integrates artificial intelligence, machine learning, and advanced computational biology to accelerate the discovery and optimization of biopharmaceuticals for difficult-to-drug targets. The company's internal pipeline consists of therapeutic candidates developed using this platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 - iBio, Inc. (0001420720) (Filer) | 2026-04-29 | English | |
| 8-K - iBio, Inc. (0001420720) (Filer) | 2026-04-08 | English | |
| 4 - iBio, Inc. (0001420720) (Issuer) | 2026-03-23 | English | |
| 4 - iBio, Inc. (0001420720) (Issuer) | 2026-03-23 | English | |
| 8-K - IBIO, INC. (0001420720) (Filer) | 2026-02-27 | English | |
| S-3 - IBIO, INC. (0001420720) (Filer) | 2026-02-27 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38584987 | 424B3 - iBio, Inc. (0001420720) (Filer) | 2026-04-29 | English | ||
| 33816158 | 8-K - iBio, Inc. (0001420720) (Filer) | 2026-04-08 | English | ||
| 33012910 | 4 - iBio, Inc. (0001420720) (Issuer) | 2026-03-23 | English | ||
| 33012908 | 4 - iBio, Inc. (0001420720) (Issuer) | 2026-03-23 | English | ||
| 32891626 | 8-K - IBIO, INC. (0001420720) (Filer) | 2026-02-27 | English | ||
| 32891629 | S-3 - IBIO, INC. (0001420720) (Filer) | 2026-02-27 | English | ||
| 29659150 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29659058 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29658712 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32891630 | 10-Q - IBIO, INC. (0001420720) (Filer) | 2026-02-10 | English | ||
| 32891628 | 8-K - IBIO, INC. (0001420720) (Filer) | 2026-02-10 | English | ||
| 19423077 | EFFECT - iBio, Inc. (0001420720) (Filer) | 2026-02-10 | English | ||
| 18510814 | 424B3 - iBio, Inc. (0001420720) (Filer) | 2026-02-09 | English | ||
| 32891624 | 4 - IBIO, INC. (0001420720) (Filer) | 2026-01-30 | English | ||
| 32891625 | 4 - IBIO, INC. (0001420720) (Filer) | 2026-01-30 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ascendis Pharma A/S
Biopharmaceutical firm using its prodrug technology to trea…
|
ASND | DK | Manufacturing |
|
Ascentage Pharma Group International
Integrated biopharma developing novel small molecule therap…
|
6855 | HK | Manufacturing |
|
ASCENTAGE PHARMA GROUP INTERNATIONAL
A clinical-stage biopharma developing novel therapies for c…
|
AAPG | US | Manufacturing |
|
Ascletis Pharma Inc.
R&D driven biotech developing best-in-class therapeutics, p…
|
1672 | KY | Manufacturing |
|
ASEP Medical Holdings Inc.
Developing diagnostic and therapeutic solutions to combat a…
|
ASEP | CA | Manufacturing |
|
ASKA Pharmaceutical Holdings CO., Ltd.
Specializes in hormone-related pharmaceuticals for internal…
|
4886 | JP | Manufacturing |
|
ASPEN PHARMACARE HOLDINGS LIMITED
Global specialty and branded pharmaceutical company deliver…
|
APN | ZA | Manufacturing |
|
Aspire Biopharma Holdings, Inc.
Develops sublingual drug delivery technologies for needle-f…
|
ASBP | US | Manufacturing |
|
ASSEMBLY BIOSCIENCES, INC.
A clinical-stage biotech developing small molecule antivira…
|
ASMB | US | Manufacturing |
|
ASSERCA S.R.L.
Specializes in importing, exporting, and manufacturing medi…
|
— | AR | Manufacturing |
iBio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35045/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35045 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35045 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35045 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35045}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for iBio, Inc. (id: 35045)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.